This
is a Phase II and Phase III open-label trial
evaluating the efficacy, and safety of Proxinium™
in patients with advanced squamous cell cancer
in the head and neck.
| Condition
|
Intervention |
Phase |
- Recurrent Squamous Cell Carcinoma
of the Head and Neck
- Persistent Squamous Cell Carcinoma
of the Head and Neck
- Carcinoma, Squamous Cell
- Neoplasms, Squamous Cell
- Head and Neck Neoplasms
- Mouth Neoplasms
- Head and Neck Cancer
|
Drug:
Proxinium |
Phase
II and Phase III |
Study
Type:
Interventional
Study
Design:
Treatment, Randomized, Open Label, Safety/Efficacy
Study
Official
Title:
A randomized, multicenter therapeutic confirmatory
study to evaluate the efficacy and safety
of Proxinium™ plus best supportive care
versus best supportive care alone in patients
with advanced squamous cell carcinoma of the
head and neck who have received at least one
anti-cancer treatment regimen for advanced
disease.
|
